| ASSET | MONTH | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | September 2017 | 17,110.88% |
HIVE Digital Technologies (HIVE) | September 2017 | 1,225% |
IZEA (IZEA) | September 2017 | 298.88% |
Anixa Biosciences (ANIX) | September 2017 | 286.76% |
Empire Petroleum (EP) | September 2017 | 280% |
Quantum Computing (QUBT) | September 2017 | 200% |
Veritone (VERI) | September 2017 | 192.66% |
Capricor Therapeutics (CAPR) | September 2017 | 188.57% |
Madrigal Pharmaceuticals (MDGL) | September 2017 | 165.02% |
Insmed (INSM) | September 2017 | 151.69% |
TDH (PETZ) | September 2017 | 148.89% |
Voyager Therapeutics (VYGR) | September 2017 | 112.27% |
Kura Oncology (KURA) | September 2017 | 106.21% |
TSS, Inc Common Stock (TSSI) | September 2017 | 100% |
Nutex Health (NUTX) | September 2017 | 95.04% |
Wetouch Technology Inc Common Stock (WETH) | September 2017 | 95% |
Applied Digital (APLD) | September 2017 | 85.71% |
Viking Therapeutics (VKTX) | September 2017 | 81.9% |
InMed Pharmaceuticals (INM) | September 2017 | 79.37% |
Savara (SVRA) | September 2017 | 78.1% |
XOMA Royalty (XOMA) | September 2017 | 76.71% |
Versus Systems Inc. (VS) | September 2017 | 75.74% |
Lunai Bioworks (LNAI) | September 2017 | 75% |
Akari Therapeutics (AKTX) | September 2017 | 71.99% |
Rocket Pharmaceuticals (RCKT) | September 2017 | 71.15% |